![PQ procedureLABS.ppt_第1页](http://file.renrendoc.com/FileRoot1/2019-12/16/56e4328d-b479-4bc7-9db1-7794dbdec533/56e4328d-b479-4bc7-9db1-7794dbdec5331.gif)
![PQ procedureLABS.ppt_第2页](http://file.renrendoc.com/FileRoot1/2019-12/16/56e4328d-b479-4bc7-9db1-7794dbdec533/56e4328d-b479-4bc7-9db1-7794dbdec5332.gif)
![PQ procedureLABS.ppt_第3页](http://file.renrendoc.com/FileRoot1/2019-12/16/56e4328d-b479-4bc7-9db1-7794dbdec533/56e4328d-b479-4bc7-9db1-7794dbdec5333.gif)
![PQ procedureLABS.ppt_第4页](http://file.renrendoc.com/FileRoot1/2019-12/16/56e4328d-b479-4bc7-9db1-7794dbdec533/56e4328d-b479-4bc7-9db1-7794dbdec5334.gif)
![PQ procedureLABS.ppt_第5页](http://file.renrendoc.com/FileRoot1/2019-12/16/56e4328d-b479-4bc7-9db1-7794dbdec533/56e4328d-b479-4bc7-9db1-7794dbdec5335.gif)
已阅读5页,还剩20页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
,prequalificationprogramme,qualitycontrollaboratories,oliviergross,jitkasabartovaprequalificationprogramme:priorityessentialmedicineshtp/psm/qsm,unprequalificationprogrammeforpriorityessentialmedicines,actionplanofunfrom2001forexpandingaccessofprioritymedicinestopatientswithhiv/aidsmalariatuberculosisreproductivehealthpotentiallyothercategoriesofproductsantiviralmedicinesefficaciousforavianfluepaediatricformulations,unprequalificationprogrammeforpriorityessentialmedicines,whopqteamworkinginco-operationwithpartnersunicefunpopulationfund(unfpa)unaidsunitaidtheglobalfundworldbankanti-malarialandanti-tbproducts:rollbackmalariaandstoptb(globaldrugfacility);hiv/aidsdepartment,elementsofprequalificationprogramme,objective:toensurequality,efficacyandsafetyofmedicinesprocuredusinginternationalfunds(e.g.gftam,unitaid)components:evaluationofquality,safetyandefficacyofprioritisedessentialmedicines,inspectionsofmanufacturersandmonitoringoftheproductsaftertheirprequalificationprequalificationofqualitycontrollaboratoriesbuildingcapacityofregulators,manufacturersandqualitycontrollaboratories,prequalificationofqclaboratories,needtoincreasetheaccesstoqclaboratoriesthatmeetrecommendedstandardsfortestingofmedicinesarecommittedtoprovideaserviceoftestingofmedicines,includingbutnotlimitedtohiv/aids,tuberculosisandmalariaproductstounagenciesprocedureestablishedin2004participationofaqclaboratoryisvoluntary,procedureforassessingtheacceptability,inprinciple,ofqualitycontrollaboratoriesforusebyunagencies,publishedin2004(whotrs,no.917,annex4)revisionpublishedin2007(whotrs,no.943,annex5)relateddocumentsgoodpracticesfornationalpharmaceuticalcontrollaboratories(whotrs,no.902annex3)whogmp:mainprinciplesforpharmaceuticalproducts.in:qualityassuranceofpharmaceuticals.acompendiumofguidelinesandrelatedmaterials.vol.2,2ndupdatededition.goodmanufacturingpracticesandinspection(geneva,worldhealthorganization,2007)guidelinesforpreparingalaboratoryinformationfile(whotrs,no.917,annex5),basedonthefollowingprinciples,relianceontheinformationsuppliedbythenationaldrugregulatoryauthoritygeneralunderstandingofthequalitycontrolactivitiesofthelaboratoryevaluationofinformationsubmittedbythelaboratoryassessmentofconsistencyinqualitycontrolthroughcompliancewithgmp(s)andwhoguidelines,invitationforexpressionofinterest,3rdeoipublishedinseptember2007/prequal/info_applicants/eoi/eoi-qclabsv3.pdfpreviousinvitationslimitedtoqclaboratoriesinafrica,currentlynoregionallimitationpriorityintheassessmentwillbegiventonationalqclaboratoriesandlaboratoriesprovidingtestingservicestothegovernmentqclaboratoriesinareaswhereunagenciesidentifytheneedforqualitytestinganylaboratory(privateorgovernmental)canparticipate,stepsoftheprocedure,expressionofinterestsubmissionoflaboratoryinformationlaboratoryinformationfile-lifneededtogetbasicinformationonlaboratorysactivitiesandsuggestedscopeofprequalificationagoodlifmakestheprocedurefasterguidelinesforpreparinglifavailabledocumentationandqasystem,personnel,handlingofsamples,materials,premises,equipment,contractoperationsandactivities,out-of-specificationinvestigation,self-inspectionstabilitytesting,microbiologicaltesting,watersystem,whereapplicablequalitymanualcanbesubmitted(amendedasnecessary)evidenceofparticipationinproficiencytestingschemes,stepsoftheprocedure,screeningofsubmittedlaboratoryinformationformalcompletenessamendmentrequested,ifnecessaryevaluationofthelaboratoryinformationwhocarriesoutevaluationoflifstoassessthelaboratoryspotentialtopasssuccessfullytheinspectionifthelifindicatesthatthelaboratorywouldcomply-whostartsarranginganinspectionifthelifisnotadequatewhostartsarranginganinventoryauditorasksformoreinformationorreturnsthelif,stepsoftheprocedure,siteinspection/inventoryauditplannedandcoordinatedbywho(normallyfor2-3days)expertsappointedbywhopreferablyfromregulatoryauthorityinspectorates,experiencedinqualitycontrolrequiredtosigndeclarationofinterestandconfidentialitydeclarationcompliancewithwhorecommendedstandardsgoodpracticesfornationalpharmaceuticalcontrollaboratoriesgoodmanufacturingpracticesasrecommendedbywhoforsuchlaboratoriesisocertificationencouragedandconsideredhowever,gmpaspectstobetakenintoaccountduringinspection,stepsoftheprocedure,siteinspection/inventoryaudit(cont.)fortheinspectionrepresentative(s)ofthedraofthecountrywherethelaboratoryislocatedinvitedinventoryauditlessformal,combinedwithdiscussionsofproblemsandassessmentofneedoftechnicalassistance,stepsoftheprocedure,reportandoutcomeofevaluationfinalreportintheestablishedwhoformatcommunicatedtothelaboratoryandacopysenttothenationaldraifcorrectiveactionstobetakenbythelaboratory,whopostponeitsfinalrecommendationsuntilthecorrectiveactionhasbeenevaluatedandfoundsatisfactoryincaseofdisagreement,possibilityofanappealownershipofthereportlieswithwhoresultsofassessmentinformationissenttothelaboratoryandnationaldraifcompliant,laboratoryisincludedinthepublishedlistandwhopirispublishedthelistwillbesubjectedtoreviewatleastonceayear,stepsoftheprocedure,re-evaluationafterprequalificationon-goingmonitoringre-inspectionsatregularintervals(normally3years)evaluationofresultsfromparticipationinproficiencytestingschemeswhoexternalqualityassurancescheme,afssapsnetworkoffrancophoneafricancountrieswhomaysuspendorwithdrawalaboratoryfromthelistwhenthereisevidenceofnoncompliance,stepsoftheprocedure,monitoringofcomplaintswhowillinvestigatecomplaintsconcerningtheresultsofanalysisorserviceprovidedbythelaboratorywrittenreportandwhereappropriaterecommendationsforactioncopyofthereporttothelaboratory,manufactureroftheproductanddraofthecountrywherethemanufacturingsiteislocateddracouldalsobeinvitedtoparticipateintheinvestigationofthecomplaintcostrecoverywhoreservestherighttochargeforthequalityassessmentprocedureonacost-recoverybasis,statusofprequalificationofqclabsnovember2007,4qclaboratoriesprequalifiedsouthafrica,cenqam-6/2005southafrica,riip-7/2005algeria,lncpp-10/2005southafrica,adcockingram8/20072qclaboratoriesneartopq11qclaboratoriesaudited,correctivemeasuresproposed6qclaboratoriesexpressedinterest,butnotsendlifyet,frequentdeficienciesandweakpoints(1),qualitysystemsopsnotcovering,notproperlymaintainednoqualityresponsiblenoornotenoughself-auditspersonnelnoqualificationsystemnotenoughtraining,notrainingprogrammesresponsibilitiesandtasksnotclearlydefinedonpersonallevel,vagueorganizationpremisestoosmallandunfitlimitedandunfitstorageareas(lotofcupboardsetc.needed)noregularenvironmental(atleasttemperature)monitoringarchivesnotgood,norsecured,frequentdeficienciesandweakpoints(2),maintenanceoftheequipmentnoproperoronlypartialqualificationsdocumentationingeneralverydeficientnotadequatetrainingbythesuppliersinthebeginningnopre-maintenanceprogrammereferencematerialsandreagentsmaintenancesystemandrecordsnotefficient,norclearnoworkingstandardssysteminstructions/methodsnoclearsystemastowhichpharmacopoeialormanufacturersmethodtousevalidations/verificationsofmethodsnotsufficientornon-existing,frequentdeficienciesandweakpoints(3),wastemanagementnotproperlyorganizedsafetyfumehoodslackingortoofewnoorinsufficientprotectionofthepersonnel(e.g.insufficientprotectivegarments,notraining,nosafetysheetsofthechemicals)noclassificationnorproperstorageofdangerouschemicalmaterials(e.g.toxics,caustic/volatilereagentsetc.),technicalassistance,technicalassistanceprovidedto5nationalmedicinesqualitycontrollaboratoriesassistanceinimplementationofqualitysystemassistanceinmicrobiologicaltesting13weekscapacitybuildingandtechnicalassistanceprovidedtonationalqclaboratoriesoutofthescopeoftheprequalificationprocedure,training,participationinqualityassurancetrainingofomclsorganizedbyedqmoctober2005,5participantsfromafroandemroseptember2007,12participantsfromafro,emroandeurotrainingsinqualityassurance,qualitycontrolandph.int.underpreparationnovember2007,morocco,40participantsfromfrancophonecountries(afro,emro),cooperationwithedqmdecember2007,tanzania,40participantsfromanglophonecountries(afro,emro)trainingsplannedin2008marketsurveillanceprojects,networkingofafricanlaboratories,samplingandtesting(1),surveyofthequalityofantiretroviralmedicinescirculatinginselectedafricancountriescarriedoutinjune-december2005,reportnowfinalized7countries(cameroon,drofcongo,kenya,nigeria,tanzania,ugandaandzambia)monocomponentproducts(didanosine,efavirenz,lamivudine,nevirapine,stavudine,zidovudine),fdcs(lamivudine/zidovudine,stavudine/lamivudine,stavudine/lamivudine/nevirapine)394samplesfromofficialprocurementandtreatmentcentres,bothprivateandpublictestingaccordingph.int.,usp,indianpharmacopoeia,validatedin-houseswissmedicmethods(laboratoryswissmedic)testsperformed-appearance,labelling,identification,uniformityofmass(capsules/tablets),dissolution/disintegration,ph(oralsolutions-dependinguponthematrix),relatedsubstances,contentofeachactiveingredient,samplingandtesting(2),surveyofthequalityofantiretroviralmedicinescirculatinginselectedafricancountries-findings,verylowfailureof1.8%,nocriticaldeficiencies1samplewithbrokentablets,2samplesinsufficientlylabelled
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024年沪教版六年级下册数学期末测试卷参考答案
- 2024培训基地出租协议
- 男幼师入职初期职业角色建构受滞机制研究
- 2024塔吊安装施工劳务分包合同
- 2024年演出经纪人之演出经纪实务通关提分题库(全优)
- 2024年演出经纪人之演出经纪实务高分题库及答案(典优)
- 2024年演出经纪人考试靶向题库(含答案)
- 2024年考研政治理论时政热点知识题库带答案(培优a卷)
- 2024年苏教版六年级下册数学期末测试卷【培优a卷】
- 2024年苏教版六年级下册数学期末测试卷及答案(必刷)
- 河北省廊坊市高中联合体2024届高三冲刺模拟物理试卷含解析
- 一个完整详细的箱涵清淤施工方案
- 上市公司财务舞弊案例分析-以雅本化学为例
- 消毒供应中心进修出科小结
- 人工智能预测出行说课课件
- 《让资源再生》(教案)五年级下册科学教科版
- 阀门行业客户需求分析
- 幼儿园食堂工作人员操作规程三
- 安徽省皖南八校2023-2024学年高三第二次大联考政治试卷(原卷版)
- 长距离管道输水安全保障措施
- 2024年山西离柳焦煤集团有限公司招聘笔试参考题库含答案解析
评论
0/150
提交评论